Research and Markets: 2011 Report on the $90 Billion US Biotechnology Product Manufacturing Industry

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/74dd8c/biotechnology_prod) has announced the addition of the "Biotechnology Product Manufacturing" report to their offering.

The US biotechnology industry includes about 1,500 companies with combined annual revenue of more than $90 billion. Major companies include Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), Genzyme, Life Technologies, and Monsanto. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably.

COMPETITIVE LANDSCAPE

Demand for biotechnology research in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. Funding for biotech research is often provided by venture capital funds hoping to cash in on new products. The profitability of individual companies depends on the discovery and effective marketing of new products. Because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research. The industry is capital intensive: average annual revenue per worker is $500,000.

Biotech firms face stiff competition from pharmaceutical and other companies seeking to be first with a new product or discovery.

PRODUCTS, OPERATIONS & TECHNOLOGY

Biotechnology is used to produce drugs, therapies, vaccines, and medical diagnostic tests. It's also used to produce genetically modified (GM) plants and crops; DNA fingerprinting; environmental biotech products that aid in the clean-up of hazardous waste.

Key Topics Covered:

Industry Overview

Quarterly Industry Update

Business Challenges

Business Trends

Industry Opportunities

Call Preparation Questions

Financial Information

Industry Forecast

Web Links and Acronyms

For more information visit http://www.researchandmarkets.com/research/74dd8c/biotechnology_prod

Source: First Research



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:   United States  North America

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.